Home Newsfeeds JP Morgan Upgrades Amphenol to Overweight

JP Morgan Upgrades Amphenol to Overweight

JP Morgan analyst Samik Chatterjee upgrades Amphenol (NYSE:APH) from Neutral to Overweight.

byBenzinga Newsdesk

July 14, 2022

1 minute read

JP Morgan analyst Samik Chatterjee upgrades Amphenol (NYSE:APH) from Neutral to Overweight.

Material Weakness In Internal Control: Dentsply Stock Falls Despite Q2 Beat – What’s Going On

By Vandana Singh

August 3, 11:45 AM

Dentsply Sirona Inc (NASDAQ: XRAY) reported Q2 adjusted EPS of $0.51, down 26% from $0.69 a year ago, beating the consensus

XRAY

Liquidity Services GovDeals’ Online Marketplace Selected By Two Government Agencies To Auction Real Estate To The Public

By Benzinga Newsdesk

August 31, 1:13 PM

MONTGOMERY, Ala., Aug. 31, 2022 (GLOBE NEWSWIRE) -- GovDeals is pleased to announce that Jacksonville, Texas and Petersburg, Virginia have joined thousands of other GovDeals sellers to sell

LQDT

Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $14

By Benzinga Newsdesk

January 5, 7:21 AM

Citigroup analyst Neena Bitritto-Garg maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $11 to $14.

ROIV

News

Coronavirus Omicron Subvariant BA.5 Surging in China May Be Evolving to Attack the Brain, Researchers Say

By Charles Gross

December 28, 6:08 AM

-South China Morning Post https://www.scmp.com/news/china/science/article/3204807/coronavirus-omicron-ba5-subvariant-may-cause-more-damage-not-less-study?module=live&pgtype=homepage

BNTX

JP Morgan Upgrades Amphenol to Overweight

Related Posts

Material Weakness In Internal Control: Dentsply Stock Falls Despite Q2 Beat – What’s Going On

Liquidity Services GovDeals’ Online Marketplace Selected By Two Government Agencies To Auction Real Estate To The Public

Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $14

Coronavirus Omicron Subvariant BA.5 Surging in China May Be Evolving to Attack the Brain, Researchers Say